Release Date: 03/09/21 08:23 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 217.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%